source

The AACR Annual Meeting is where new modalities and targets debut, each April.

ADC Review covers everything ADC: deals, payload chemistry, and monthly pipeline summaries.

The American Cancer Society is the largest US cancer charity. It publishes the annual US cancer statistics that most news reports quote, screening recommendations that differ from the US Preventive Services Task Force in places (colorectal screening from 45, for example), and plain-language patient guides for every cancer.

ASCO Daily News is the American Society of Clinical Oncology's free news service, published daily during meetings and weekly otherwise, covering sessions as they happen and guideline updates. It is most useful during the Annual Meeting, when it adds expert perspective to the abstracts.

The primary record of what was presented at ASCO meetings each year.

The ASH Annual Meeting is December's blood-cancer summit, bringing CAR-T, bispecifics, menin, BTK, and myeloma news.

The ASTRO Annual Meeting is where hypofractionation, SBRT, protons, FLASH, and MR-guided radiotherapy results appear.

BioCentury writes analysis for people who make decisions about pipelines.

BioPharma Dive offers clean, free industry reporting and is good for deal and approval context.

The Breast Cancer Research Foundation's weekly blog explains new breast cancer research findings and drug approvals in plain terms for a general audience, and reports on the research the foundation funds. It is free, and it bridges the research literature and patient-facing news.

Cancer Research UK's About Cancer pages give clear UK patient information, including NHS treatment pathways.

CancerNetwork publishes daily practice-oriented news across solid and haematologic cancers.

Dimensions connects papers to the grants and trials behind them.

The EMA's CHMP highlights show Europe's approval pipeline one month ahead of European Commission decisions.

Endpoints News is the fastest read on what biotech and pharma are doing in oncology, deal by deal.

ESMO Congress, held each October by the European Society for Medical Oncology, is Europe's largest oncology meeting and the autumn counterpart to ASCO, where phase 3 trials now regularly report for the first time. Abstracts are free in Annals of Oncology; other content is for registrants.

Evaluate Vantage forecasts which drugs and modalities will matter commercially in the next decade.

Fierce Biotech is where trial failures get reported plainly.

Healio Hematology/Oncology publishes clinician-facing daily news with good approval and lifestyle-risk coverage.

Congress results translated for people with breast cancer, fast and accurately.

Macmillan Cancer Support covers the practical side of cancer: money, work, coping, and where to get help.

Medscape Oncology publishes broad clinician news with continuing-education tie-ins.

Nature Briefing: Cancer is one email a week that catches the papers you missed.

NICE technology appraisals say whether the NHS will pay, and why. They are the most transparent HTA record in the world.

npj Precision Oncology is a Nature Portfolio journal that publishes genomics, artificial intelligence and biomarker studies continuously rather than in issues. Every article is open access under a CC BY licence, so it can be read in full without a subscription.

OncLive, run by MJH Life Sciences, publishes daily oncology news, approval alerts and video interviews with trial investigators, often within hours of a readout. Industry-sponsored content is common, so check numbers against the primary source before relying on them.

OncoDaily publishes a high volume of daily oncology news, education and career items from outside the United States, which is the perspective US-centred feeds lack. It is free, but trial news is mixed with profiles and history pieces, so check primary sources before reusing a figure.

PanCAN is the leading pancreatic cancer patient organisation; it pioneered free tumour molecular profiling for patients (Know Your Tumor) and runs an adaptive platform trial for a disease with few options.

The San Antonio Breast Cancer Symposium, run by UT Health San Antonio, the AACR and Baylor, packs the year's breast cancer evidence into one week each December. Abstracts are free and appear in Cancer Research and Clinical Cancer Research supplements.

Semantic Scholar offers free literature search with machine-generated summaries and citation context.

The SNMMI Annual Meeting, held each June by the Society of Nuclear Medicine and Molecular Imaging, is where new PET tracers, radioligand therapy results and dosimetry work are first presented. Abstracts are free as a Journal of Nuclear Medicine supplement, and that journal carries the field's papers through the rest of the year.

STAT News has the best-written reporting on the science and business of cancer, with real scepticism.

Targeted Oncology is OncLive's sibling with a biomarker and targeted-therapy focus.

The ASCO Post gives reliable, clinician-written summaries of the trials that matter, usually within days.

The Cancer Letter tells the inside story of cancer institutions and policy. Nobody else covers NCI and the centres this closely.

The Triple Negative Breast Cancer Foundation runs a free site with information written for this subtype, a helpline staffed by oncology social workers, support groups, webinars and clinical trial listings. It is the dedicated patient resource for a subtype that general breast cancer sites cover only in passing.

UroToday is the prostate, bladder, and kidney cancer feed, including PSMA and radioligand news.